|
|
Volumn 18, Issue 6, 1995, Pages 436-440
|
|
Prolactinoma in 53 men: Clinical characteristics and modes of treatment (male prolactinoma)
a
|
|
Author keywords
dopamine antagonists; men; pituitary adenoma; Prolactin
|
|
Indexed keywords
BROMOCRIPTINE;
DOPAMINE RECEPTOR STIMULATING AGENT;
ERGOT ALKALOID;
FOLLITROPIN;
HYDROCORTISONE;
LIOTHYRONINE;
LISURIDE MALEATE;
LUTEINIZING HORMONE;
PERGOLIDE MESILATE;
PROLACTIN;
TESTOSTERONE;
THYROTROPIN;
THYROXINE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED STUDY;
FOLLITROPIN BLOOD LEVEL;
HUMAN;
HYDROCORTISONE BLOOD LEVEL;
HYPERPROLACTINEMIA;
LIOTHYRONINE BLOOD LEVEL;
LUTEINIZING HORMONE BLOOD LEVEL;
MAJOR CLINICAL STUDY;
MALE;
MICROADENOMA;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PROLACTIN BLOOD LEVEL;
PROLACTINOMA;
SEXUAL FUNCTION;
TESTOSTERONE BLOOD LEVEL;
THYROTROPIN BLOOD LEVEL;
THYROXINE BLOOD LEVEL;
TUMOR VOLUME;
VISUAL FIELD DEFECT;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
COMBINED MODALITY THERAPY;
DOPAMINE AGONISTS;
HUMAN;
MALE;
MIDDLE AGE;
MULTIPLE ENDOCRINE NEOPLASIA;
PITUITARY HORMONES;
PITUITARY NEOPLASMS;
PROLACTIN;
PROLACTINOMA;
RETROSPECTIVE STUDIES;
|
|
EID: 0029149549
PISSN: 03914097
EISSN: 17208386
Source Type: Journal
DOI: 10.1007/BF03349742 Document Type: Article |
|
Times cited : (71)
|
|
References (15)
|
